CA IX-specific inhibitors

Details for Australian Patent Application No. 2012211499 (hide)

Owner Scozzafava, A. Institute of Virology Supuran, C.

Inventors Scozafava, Andrea; Pastorekova, Silvia; Pastorek, Jaromir; Supuran, Claudiu

Agent Spruson & Ferguson

Pub. Number AU-A-2012211499

Parent 2010200368

Filing date 10 August 2012

Wipo publication date 30 August 2012

International Classifications

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/18 - Sulfonamides

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61K 31/428 - condensed with carbocyclic rings

A61K 31/47 - Quinolines

A61K 31/505 - Pyrimidines

C12N 9/88 Enzymes, e.g. ligases (6.) - Lyases (4.)

C12Q 1/527 Measuring or testing processes involving enzymes or micro-organisms - involving lyase

Event Publications

30 August 2012 Application Open to Public Inspection

  Published as AU-A-2012211499

30 August 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012211500-Humanized anti-CD70 binding agents and uses thereof

2012211498-Methods and apparatus for characterizing media